These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 17316372
1. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C. Tjørhom A, Riiser A, Carlsen KH. Scand J Med Sci Sports; 2007 Dec; 17(6):628-35. PubMed ID: 17316372 [Abstract] [Full Text] [Related]
2. The effect of formoterol inhalation on endurance performance in hypobaric conditions. Riiser A, Tjørhom A, Carlsen KH. Med Sci Sports Exerc; 2006 Dec; 38(12):2132-7. PubMed ID: 17146320 [Abstract] [Full Text] [Related]
3. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P. Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313 [Abstract] [Full Text] [Related]
4. Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers. Sue-Chu M, Sandsund M, Helgerud J, Reinertsen RE, Bjermer L. Scand J Med Sci Sports; 1999 Feb; 9(1):48-52. PubMed ID: 9974197 [Abstract] [Full Text] [Related]
5. Montelukast does not affect exercise performance at subfreezing temperature in highly trained non-asthmatic endurance athletes. Sue-Chu M, Sandsund M, Holand B, Bjermer L. Int J Sports Med; 2000 Aug; 21(6):424-8. PubMed ID: 10961518 [Abstract] [Full Text] [Related]
6. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I, Hall IP, McFarlane LC, Lipworth BJ. J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [Abstract] [Full Text] [Related]
7. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers. Sandsund M, Sue-Chu M, Helgerud J, Reinertsen RE, Bjermer L. Eur J Appl Physiol Occup Physiol; 1998 Mar; 77(4):297-304. PubMed ID: 9562357 [Abstract] [Full Text] [Related]
8. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Ferrari M, Balestreri F, Baratieri S, Biasin C, Oldani V, Lo Cascio V. Respiration; 2000 Mar; 67(5):510-3. PubMed ID: 11070454 [Abstract] [Full Text] [Related]
9. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol. Goldkorn A, Diotto P, Burgess C, Weatherall M, Holt S, Beasley R, Siebers R. Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610 [Abstract] [Full Text] [Related]
14. Enhancement of exercise performance with inhaled albuterol. Bedi JF, Gong H, Horvath SM. Can J Sport Sci; 1988 Jun; 13(2):144-8. PubMed ID: 3293733 [Abstract] [Full Text] [Related]
15. The use of inhaled formoterol in the treatment of asthma. Berger WE. Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [Abstract] [Full Text] [Related]
16. Ergogenic effect of inhaled beta 2-agonists in asthmatics. Schmidt A, Diamant B, Bundgaard A, Madsen PL. Int J Sports Med; 1988 Oct; 9(5):338-40. PubMed ID: 2907749 [Abstract] [Full Text] [Related]
17. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. van Baak MA, de Hon OM, Hartgens F, Kuipers H. Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835 [Abstract] [Full Text] [Related]
18. Formoterol provides long-lasting protection against exercise-induced bronchospasm. Bronsky EA, Yegen U, Yeh CM, Larsen LV, Della Cioppa G. Ann Allergy Asthma Immunol; 2002 Oct; 89(4):407-12. PubMed ID: 12392386 [Abstract] [Full Text] [Related]
19. Protective effect and duration of action of formoterol aerosol on exercise-induced asthma. Patessio A, Podda A, Carone M, Trombetta N, Donner CF. Eur Respir J; 1991 Mar; 4(3):296-300. PubMed ID: 1677894 [Abstract] [Full Text] [Related]
20. Influence of a beta2-agonist on physical performance at low temperature in elite athletes. Larsson K, Gavhed D, Larsson L, Holmér I, Jorfelt L, Ohlsén P. Med Sci Sports Exerc; 1997 Dec; 29(12):1631-6. PubMed ID: 9432097 [Abstract] [Full Text] [Related] Page: [Next] [New Search]